Tolerance of two ampicillin esters: a comparison of pivampicillin and bacampicillin

Pharmatherapeutica. 1983;3(6):398-404.

Abstract

The tolerability of tablets containing the ampicillin esters, pivampicillin and bacampicillin were compared clinically in 138 patients and by gastroscopy in 2 healthy volunteers. The clinical study showed no difference in tolerability, 26% of patients taking pivampicillin and 23% of those taking bacampicillin reported side-effects. Both preparations were equally effective clinically: 94% of patients taking pivampicillin and 91% of those taking bacampicillin were cured or improved. Gastroscopy showed that the pivampicillin tablets disintegrated more rapidly (10 minutes) than bacampicillin tablets (36 minutes). After disintegration, the pivampicillin tablets covered a larger area of the gastric mucosa than did tablets of bacampicillin.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Ampicillin / adverse effects
  • Ampicillin / analogs & derivatives*
  • Ampicillin / therapeutic use
  • Child
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pivampicillin / adverse effects*
  • Pivampicillin / therapeutic use
  • Prostatitis / drug therapy
  • Respiratory Tract Infections / drug therapy
  • Urinary Tract Infections / drug therapy

Substances

  • Pivampicillin
  • Ampicillin
  • bacampicillin